Swedish Cancer Society grants nearly SEK 30 million to MedH researchers
We congratulate the eight researchers at the Department of Medicine, Huddinge who have been awarded grants from the Swedish Cancer Society (Cancerfonden) for the period 2025-2029. Together, the MedH researchers are awarded grants of nearly SEK 30 million.
Karl Ekwall, Biosciences and Nutrition Unit.
Title: Chromatin remodeling and histone modifications in cellular quiescence.
Amount granted for 2025-2026: SEK 3 000 000.
Petter Höglund, Hematology Unit/HERM.
Title: Platelet function in leukemia and immune responses to platelet transfusions: clinical and experimental
studies.
Amount granted for 2025-2027: SEK 3 750 000.
Martin Jädersten, Hematology Unit/HERM.
Title: Targeting SAMHD1 in relapsed/refractory AML: The FLAsH-IV trial.
Amount granted for 2025-2029: SEK 5 000 000.
Isabelle Magalhaes, Hematology Unit/HERM.
Title: Identification of cytotoxic, resilient MSLN CAR T cells for solid tumors treatment.
Amount granted for 2025-2027: SEK 3 000 000.
Karl-Johan Malmberg, Center for Infectious Medicine (CIM).
Title: Off-the-shelf Adaptive NK Cell Therapy Guided by Protein Biologics and Precision Engineering.
Amount granted for 2025-2027: SEK 5 250 000.
Magnus Tobiasson, Hematology Unit/HERM.
Title: Exploring Stem and Immune Cell Dynamics Post- Relapse in Myelodysplastic Syndrome Patients Following Allogeneic Stem Cell Transplantation.
Amount granted for 2025-2027: SEK 3 000 000.
Eckardt Treuter, Biosciences and Nutrition Unit.
Titel: Role of epigenetic monocyte alterations in linking inflammatory type 2 diabetes and cancer via tumor-associated macrophages
Amount granted for 2025-2027: SEK 3 750 000.
Arnika Wagner, Hematology Unit/HERM.
Title: Identification and Elucidation of druggable targets to increase NK cells functions against Cancer.
Amount granted for 2025-2027: SEK 3 000 000.